CERT - Certara, Inc.
11.73
0.110 0.938%
Share volume: 1,389,083
Last Updated: 03-07-2025
Computer Software/Services – Computer Programming And Data Processing:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$11.62
0.11
0.01%
Fundamental analysis
27%
Profitability
0%
Dept financing
23%
Liquidity
75%
Performance
43%
Performance
5 Days
0.95%
1 Month
-15.37%
3 Months
3.17%
6 Months
6.83%
1 Year
-38.33%
2 Year
-42.27%
Key data
Stock price
$11.73
DAY RANGE
$11.13 - $11.95
52 WEEK RANGE
$9.41 - $19.29
52 WEEK CHANGE
-$37.74
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail

CEO: William F. Feehery
Region: US
Website: certara.com
Employees: 350
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services
Region: US
Website: certara.com
Employees: 350
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. The company also provides related technology- enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Recent news